Lincoln Pharmaceuticals Ltd (NSE:LINCOLN) Share Price

Company Profile

Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, it carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
IND
T: +91 7941078000
https://www.lincolnpharma.com
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2026
Employees
1,919

Recommended

Simplification plan complete, organic growth now the focus.

Nathan Zaia | 20 August 2025

Cost containment and growing revenue bode well for profit margins.

Adrian Atkins | 20 August 2025

Sales growth at CSL was lower than expected but streamlining the business has its perks.

Shane Ponraj, CFA | 19 August 2025

Index	Last price	Change	% Change
All Ordinaries	9,177.40	3.60	0.04%
CAC 40	7,973.03	6.05	-0.08%
DAX 40	24,276.97	146.10	-0.60%
Dow JONES (US)	44,938.31	16.04	0.04%
FTSE 100	9,288.14	98.92	1.08%
HKSE	25,165.94	43.04	0.17%
NASDAQ	21,172.86	142.09	-0.67%
Nikkei 225	42,888.55	657.74	-1.51%
NZX 50 Index	13,153.01	81.71	0.63%
S&P 500	6,395.78	15.59	-0.24%
S&P/ASX 200	8,918.00	21.80	0.25%
SSE Composite Index	3,766.21	38.92	1.04%